These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12666267)

  • 21. Uneventful long-term anticoagulation with fluindione in a patient with severe factor XI deficiency.
    Bauduer F
    Haemophilia; 2015 Jan; 21(1):e72-3. PubMed ID: 25421862
    [No Abstract]   [Full Text] [Related]  

  • 22. Can colchicine potentiate the anticoagulant effect of fluindione?
    Gras-Champel V; Ohlmann P; Polard E; Wiesel ML; Imbs JL; Andréjak M
    Eur J Clin Pharmacol; 2005 Aug; 61(7):555-6. PubMed ID: 16007421
    [No Abstract]   [Full Text] [Related]  

  • 23. [Liver toxicity associated with oral anticoagulant treatment: report of two cases].
    Walter T; Lot M; Guillaud O; Vial T; Boillot O; Dumortier J
    Gastroenterol Clin Biol; 2007; 31(6-7):615-6. PubMed ID: 17646791
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute immuno-allergic interstitial nephritis caused by fluindione.
    Belmouaz S; Desport E; Abou Ayache R; Thierry A; Mignot A; Bauwens M; Goujon JM; Bridoux F; Touchard G
    Clin Nephrol; 2006 Dec; 66(6):455-8. PubMed ID: 17176918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
    Daveluy A; Milpied B; Barbaud A; Lebrun-Vignes B; Gouraud A; Laroche ML; Ciobanu E; Bégaud B; Moore N; Miremont-Salamé G; Haramburu F;
    Eur J Clin Pharmacol; 2012 Jan; 68(1):101-5. PubMed ID: 21792562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute and chronic nephropathy induced by fluindione must be addressed.
    Cam G; Kwetcheu AT; Vigneau C; Siohan P; Queffeulou G; Gatault P; Laruelle E; Crémault A; Le Cacheux P; Rioux-Leclercq N; Renaudineau E
    Nephrol Dial Transplant; 2012 Apr; 27(4):1554-8. PubMed ID: 21931126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholestatic hepatitis after diagnostic ajmaline challenge.
    Hamoir C; Dano H; Komuta M; Druez P; Negrin Dastis S
    Acta Gastroenterol Belg; 2017; 80(3):425-426. PubMed ID: 29560676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cholestatic hepatitis caused by midecamycin].
    Pérez Moreno JM; Saldaña González FJ; Puertas Montenegro M; Báez Perea J
    Gastroenterol Hepatol; 1996 Nov; 19(9):459-61. PubMed ID: 8998670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivaroxaban Associated Cholestatic Jaundice.
    Krishnan P; Ramadas P; Gangireddy R
    Am J Ther; 2018; 25(4):e500-e501. PubMed ID: 28410245
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia].
    Lee JY; Park EB; Ahn JH; Suh SJ; Jung YK; Kim JH; Shin BK; Yang JH; Yeon JE; Byun KS
    Korean J Hepatol; 2008 Mar; 14(1):102-7. PubMed ID: 18367863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis caused by various derivatives of erythromycin].
    Funck-Brentano C; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1983 Apr; 7(4):362-9. PubMed ID: 6347792
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction between paracetamol and oral anticoagulants.
    Ornetti P; Ciappuccini R; Tavernier C; Maillefert JF
    Rheumatology (Oxford); 2005 Dec; 44(12):1584-5. PubMed ID: 16204376
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms and in vitro models of drug-induced cholestasis.
    Gijbels E; Vilas-Boas V; Deferm N; Devisscher L; Jaeschke H; Annaert P; Vinken M
    Arch Toxicol; 2019 May; 93(5):1169-1186. PubMed ID: 30972450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cholestatic hepatitis associated with tenoxicam].
    Pascual AF; Jiménez Martos F; Rodríguez Moreno C
    Aten Primaria; 1995 Mar; 15(5):329. PubMed ID: 7734692
    [No Abstract]   [Full Text] [Related]  

  • 35. [Phenprocoumon-induced cholestatic hepatitis].
    Woolley S; Burger HR; Zellweger U
    Dtsch Med Wochenschr; 1995 Nov; 120(44):1507-10. PubMed ID: 7588020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
    Daveluy A; Géniaux H; Thibaud L; Mallaret M; Miremont-Salamé G; Haramburu F
    Therapie; 2014; 69(6):519-20. PubMed ID: 25230280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recurrent pyoderma gangrenosum-like ulcers induced by oral anticoagulants].
    Pralong P; Debarbieux S; Paret N; Balme B; Depaepe L; Nosbaum A; Ben-Said B; Nicolas JF; Bérard F
    Ann Dermatol Venereol; 2014 Jan; 141(1):34-8. PubMed ID: 24461092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose venlafaxine-associated liver toxicity in chronic hepatitis.
    Sencan I; Sahin I; Ozcetin A
    Ann Pharmacother; 2004 Feb; 38(2):352-3. PubMed ID: 14742779
    [No Abstract]   [Full Text] [Related]  

  • 39. Risperidone-induced cholestatic hepatitis.
    Krebs S; Dormann H; Muth-Selbach U; Hahn EG; Brune K; Schneider HT
    Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):67-9. PubMed ID: 11204814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin necrosis due to fluindione treatment: a rare but serious complication.
    Beqqal K; Horellou MH; Philippe A; Alhene Gelas M; Flaujac C; Gorin I; Jacobelli S; Dupin N; Hassam B; Avril MF
    J Wound Care; 2014 Feb; 23(2 Suppl):S16-9. PubMed ID: 24526169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.